Increased Isolation and Characterization of Shigella sonnei Obtained from Hospitalized Children in Tehran, Iran by Ranjbar, Reza et al.
©INTERNATIONAL CENTRE FOR DIARRHOEAL
DISEASE RESEARCH, BANGLADESH
J HEALTH POPUL NUTR  2008 Dec;26(4):426-430
ISSN 1606-0997 | $ 5.00+0.20
Increased Isolation and Characterization of  
Shigella sonnei Obtained from Hospitalized 
Children in Tehran, Iran
Reza Ranjbar1, Mohammad M. Soltan Dallal2, Malihe Talebi3, and Mohammad R. Pourshafie3
1Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran, 2Department of Pathobiology, 
School of Public Health and Institute of Public Health Research, Tehran University of Medical Science, and 3Department of 
Microbiology, Pasteur Institute of Iran, Tehran, Iran
ABSTRACT
Shigella flexneri has been the most frequent cause of shigellosis in children in Iran. To evaluate the changes 
in frequency of serogroups, 302 Shigella species were isolated in 2003 from hospitalized children, aged less 
than 12 years, with acute diarrhoea in Tehran, Iran. The number of collected S. sonnei, S. flexneri, S. boydii, 
and S. dysenteriae isolates was 178 (58.9%), 110 (37.4%), 10 (3.3%), and 4 (1.3%) respectively. Most (94%) 
S. sonnei isolates were resistant to co-trimoxazole. They were, however, relatively or completely sensitive 
to 15 commonly-used antibiotics. The extracted plasmids showed 12 different profiles with two closely-
related patterns constituting 70% of the total isolates. Ribotyping, using PvuII, HindIII or SalI restriction 
enzymes, generated a single pattern for all S. sonnei isolates. Data suggest that S. sonnei has become the 
predominant serogroup in children in the hospitals of Tehran. 
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INTRODUCTION
Shigella is the major cause of diarrhoeal diseases in 
both developing and developed countries (1). In 
some developing countries, it was made up of 10% 
of all diarrhoeal cases during the 1990s among chil-
dren aged ≤5 years (2).
Of the Shigella species, Shigella flexneri and S. sonnei 
are the most prevalent serogroups found in develop-
ing and industrialized countries respectively. S. dys-
enteriae is seen mostly in South Asia and sub-Saharan 
Africa, and S. boydii has been reported worldwide 
with about 4% of the total shigellosis cases (1).
For many years, S. flexneri has been the predominant 
isolate in Iran (3,4). The present study was conduct-
ed to examine the prevalence of Shigella spp., anti-
biotic susceptibility patterns, and genetic character-
ization of S. sonnei isolates. We report here for the 
first time that S. sonnei was the most frequent isolate 
among shigellosis cases in children in Tehran.
MATERIALS AND METHODS
Patients
The study included all patients, aged less than 12 
years, with diarrhoea (three times or more watery 
or soft defaecations per 24 hours that had lasted for 
≤7 days, fever, abdominal pain, tenesmus with or 
without nausea, and vomiting), who were admit-
ted to three large hospitals: Children Medical Cen-
ter, Mofid Hospital, and Millad Hospital, in Tehran, 
Iran, during 2003. 
A single specimen was obtained from each patient, 
and rectal swabs were collected from patients on 
the day of admission at the hospital. When the iso-
lates were identified as Shigella by the conventional 
methods (5), these were serotyped using slide ag-
glutination with specific antisera (MAST Group 
LTD, Merseyside, UK).   
Testing of antimicrobial susceptibility 
Antimicrobial susceptibility test was performed ac-
cording to the standard guideline of the Clinical Ranjbar R et al. Characterization of Shigella sonnei from children in Iran
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and Laboratory Standards Institute (6) using 16 
antibiotic discs (Becton Dickinson and Company, 
Sparks, MD, USA), such as ampicillin (10 μg), cefix-
ime (5 μg), cefotaxime (30 μg), ceftazidime (30 μg), 
ceftizoxime (30 μg), cephalothin (30 μg), cephalex-
ine (30 μg), amikacin (30 μg), gentamicin (10 μg), 
kanamycin (30 μg), ciprofloxacin (5 μg), nalidixic 
acid (30 μg), chloramphenicol (30 μg), nitrofuran-
toin (300 μg), furazolidone (100 μg), and co-tri-
moxazole (1.25/23.75 μg). Escherichia coli ATCC 
25922 was used as a quality-control strain. 
Plasmid profiling
A high-pure plasmid isolation kit (Roche, Mannh-
eim, Germany) was used for isolating bacterial 
plasmids as per the instructions of the manu- 
facturer. Extracted plasmids were then separated 
on a 0.8% agarose gel in Tris-borate-EDTA buffer 
(TBE×1) (pH 8.2) by electrophoresis. The strains 
were grouped depending on the pattern of the 
plasmid DNA bands. The banding patterns 
were interpreted by Dice analysis and clustered 
by the unweighted pair group method with arith-
metic averages (UPGMA) with Gelcompar II, 
version 4.0 (Applied Maths, Sint-Matens-latem, 
Belgium).
Ribotyping
Ribotyping was performed using standard methods 
as reported in the previous studies (7).  Bacterial DNA 
was digested with restriction enzymes (PvuII, Hin-
dIII, SalI) under the conditions recommended by 
the manufacturer (Roche Diagnostics, Mannheim, 
Germany). Digested DNA fragments were resolved 
on a 0.8% agarose gel in Tris-borate-EDTA buffer (pH 
8.2) and then transferred onto nylon membrane by 
the alkali-blotting procedure with a vacuum blot-
ter. Hybridization was performed with the probes 
labelled with digoxigenin-11-dUTP (DIG) (7). The 
membranes were then visualized by adding alkaline 
phosphate-conjugated anti-digoxigenin antibody 
(Roche Diagnostic GmbH, Mannheim, Germany) 
and 5-bromo-4-chloro-3-indolyl phosphate substrate 
and nitroblue tetrazolium. Citrobacter koseri strain 
CIP 105177 (collection: de l’Institut Pasteur) DNA 
was cleaved by MluI restriction endonuclease, and 
the fragments were used as molecular size standards.
RESULTS
Of 3,050 patients with acute diarrhoea, 302 were 
diagnosed as having shigellosis based on clinical 
presentations and laboratory findings. The isolated 
Shigella strains were distributed thus: S. sonnei 178 
(58.9%), S. flexneri 110 (36.4%), S. boydii 10 (3.3%), 
and S. dysenteriae 4 (1.3%).  
Results of further examination of the S. sonnei 
strains showed that most (≥94%) S. sonnei isolates 
were resistant to co-trimoxazole, and ≤6% of the 
isolates were resistant to nalidixic acid, ampicillin, 
chloramphenicol, cefixime, and kanamycin.  None 
of the tested isolates was resistant to ceftizoxime, 
ceftazidime, gentamicin, ciprofloxacin, amikacin, 
furazolidone, cephalothin, cefotaxime, cephalex-
ine, and nitrofurantoin. Only 2.6% of the isolates 
were resistant to ≥3 antibiotics (Table). 
Plasmid analysis of clinical isolates of S. sonnei re-
sulted in 12 different plasmid profiles with 2-9 
DNA bands (Fig. 1). The plasmids larger than 20 kb 
were not analyzed because of their instability (8,9). 
Furthermore, the plasmid isolation kit, used in this 
study, is suitable for purification of small plasmids. 
Figure 1 shows that some DNA bands (5.1 and 2.0 
kbp) were evident in most strains. No similarity in 
the plasmid pattern between our clinical isolates 
and ATCC type strain 9290 was observed. The S. 
sonnei isolates containing the plasmid profile la-
belled as P2 and P13 harboured the lowest (3) and 
the highest (9) number of DNA bands respectively. 
P3 (39%) was the dominant type of plasmid profile, 
followed by P6 (31%) (Table). 
Ribotyping was performed using three restriction 
enzymes, including PvuII, HindIII, and SalI, for all 
the S. sonnei isolates (Fig. 2). Ribotyping using SalI 
produced seven fragments ranging from 2.0 to 
12.5 kbp. The highest number of DNA fragments 
was obtained when DNA was digested with PvuII 
restriction enzyme, resulting in 13 fragments rang-
ing from 1.8 to 14 kb. HindIII showed 11 bands 
each from 2.4 to 10 kbp. Only a single ribotype 
pattern was observed using each of the restriction 
enzymes. 
DISCUSSION
S. sonnei has been the predominant Shigella spp. in 
Europe and North America (10). Whereas, S. flexneri 
has been reported to be the most frequent Shigella 
spp. in many developing countries, including the 
Middle East region (11).
In the previous years, several investigators in Tehran 
reported that the majority (61%) of shigellosis cases 
in  all  age-groups  were caused  by  S.  flexneri  (61%), 
followed by S. sonnei (31%) (3,4). The results of this 
study have shown that S. sonnei has replaced S. flexneri 
as the predominant serogroup in children aged less 
than 12 years in the hospitals in Tehran. More re-Ranjbar R et al. Characterization of Shigella sonnei from children in Iran
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cently, Farshad and colleagues also identified S. sonnei 
as the most prevalent Shigella species in Shiraz, Iran, 
in a six-month study conducted in 2003 (12).
A multicentre study has shown that S. flexneri has 
been the most frequent isolate in Bangladesh, Chi-
na, Pakistan, Indonesia, and Viet Nam (13). In the 
Table. Plasmid profiles and antimicrobial resistance patterns of S. sonnei
Plasmid  
pattern
% of isolates 
     Resistance
      pattern (%)
Resistance 
phenotype
P1 ATCC 9290* - -
P2 1.3 R4 (1.3) SXT, K 
P3 38.7 R1 (32.5)
R2 (5)
R4 (1.3)
SXT 
SXT, NA
SXT, K 
P4 6.2 R1 (5)
R3 (1.3)
SXT 
K
P5 1.3 R1 (1.3) SXT
P6 31.2 R1 (28.8)
R7 (1.3)
R5 (1.3)
SXT 
AM, SXT, K 
SXT, CFM
P7 3.8 R1 (3.8) SXT 
P8 3.8 R1 (3.8) SXT 
P9 1.3 R6 (1.3) SXT, NA, C, K
P10 2.5 R1 (2.5) SXT 
P11 6.2 R1 (6.2) SXT 
P12 1.3 R1 (1.3) SXT 
P13 2.5 R1 (2.5) SXT 
*ATCC 9290 type strain was sensitive to all antibiotics; AM=Ampicillin; C=Chloramphenicol; 
CFM=Cefixime; K=Kanamycin; NA=Nalidixic acid; SXT=Co-trimoxazole
Fig. A UPGMA dendrogram showing distribution of plasmid proﬁles of S. sonnei isolates 
Plasmid pattern
UPGMA, Dice coefﬁcient
Lane 1=Plasmid proﬁle of type strain ATCC 9290; Lane 2-13: Representative plasmid proﬁles of
clinical samples. Solid arrow and broken arrow indicate 5.1 and 2.0 kbp DNA bands evident in
most isolates; UPGMA=Unweighted pair group method with arithmetic averages
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same report, S. sonnei has been shown as the most 
predominant isolate in Thailand. It was suggested 
that the reason for S. sonnei to be the principal iso-
late is the fact that Thailand is rapidly becoming an 
industrialized country (13). Similarly, Tehran is on 
the verge of becoming an industrialized city, and 
the decrease in the proportion of S. flexneri and an 
increase in S. sonnei may reflect the hygienic im-
provement in Tehran during recent years. Such a 
shift in the serotypes of Shigella has also been re-
ported from India and Chile (14,15).
The resistance of Shigella isolates to the first-line 
antimicrobial agents has been reported in a num-
ber of countries and is increasing worldwide with 
increased mortality (16). With the exception of 
co-trimoxazole, the large majority (87%) of the iso-
lates were relatively sensitive to 15 other antibiot-
ics tested, indicating that the resistance of S. sonnei 
to drugs is not at an alarming rate in Iran. In the 
United States, the most common resistance among 
S. sonnei isolates was against ampicillin (77%) and 
co-trimoxazole (37%) (17). An increased resistance 
has been reported in developing countries, such 
as Chile and Bangladesh, for ampicillin (82%), co-
trimoxazole (65%), and chloramphenicol (49%) 
(15,18). 
Genetic characterization by plasmid profiling and 
ribotyping was also performed on our S. sonnei iso-
lates. Tacket and colleagues investigated the plas-
mid profile of 10 S. sonnei isolates and found 10 
different patterns (19). In other studies, 61 S. sonnei 
strains resulted in identification of 42 distinct plas-
mid patterns (20). These studies may suggest the 
existence of a large number of different plasmids 
in the S. sonnei populations. We found 12 differ-
ent plasmid patterns among our S. sonnei isolates. 
The presence of a common 5.1-kbp plasmid band 
was evident when comparing the plasmid bands in 
our samples with the report by other investigators 
(8,21), suggesting a widespread dissemination of 
this plasmid DNA among S. sonnei isolates in differ-
ent regions of the world.
Although some researchers have obtained variable 
results with ribotyping, the technique has been in-
dicated to be useful for epidemiological studies of S. 
sonnei (22). Hinojosa-Ahmuda and colleagues have 
found six ribotypes when 100 S. sonnei were stud-
ied using SalI restriction enzyme (23). Nastasi and 
colleagues have also found 13 ribotypes by examin-
ing 432 S. sonnei isolates (24). Several investigators 
have reported the presence of a single ribotype pat-
tern in their S. sonnei isolates which were obtained 
from outbreaks or sporadic cases (9). In our study, 
we also observed a single ribotype pattern among 
the S. sonnei isolates collected in Tehran. 
The results suggest that S. sonnei has replaced S. 
flexneri as the predominant serogroup in children 
aged less than 12 years in the hospitals in Tehran. 
The single ribotype dominance was also support-
ed by the data that 70% of the isolates harboured 
closely-related plasmid patterns labelled as P3 and 
P6. The dominance of an S. sonnei ribotype is inter-
esting when it is considered that the isolates were 
obtained from different hospitals located in a large 
geographical area in Tehran. The results further 
confirm that continuous monitoring is needed for 
over a prolonged period in Tehran to detect the 
changes in the distribution of  serotypes and the 
antimicrobial resistance pattern of Shigella.
Fig. 2. Ribotyping of S. sonnei strain
Citrobacter koseri   DNA was digested by MluI 
which served as a molecular size marker (M); 
S. sonnei DNA was digested with either HindIII 
(lane 1), SalI (lane 2), or PvuII (lane 3). All the 
isolates showed the same restriction pattern 
when digested with a single enzyme
M123
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